GV 2019 L.P. 13D and 13G filings for Prime Medicine, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-29 4:15 pm Purchase |
2024-02-20 | 13G | Prime Medicine, Inc. PRME |
GV 2019 L.P. | 15,062,498 12.200% |
3,200,000 (+26.98%) |
Filing |
| 2024-02-09 4:09 pm Sale |
2023-12-31 | 13G | Prime Medicine, Inc. PRME |
GV 2019 L.P. | 11,862,498 12.200% |
-1,422,190 (-10.71%) |
Filing |
| 2023-02-10 4:05 pm Purchase |
2022-12-31 | 13G | Prime Medicine, Inc. PRME |
GV 2019 L.P. | 13,284,688 13.700% |
13,284,688 (New Position) |
Filing |